Download PDFPDF

Tumour necrosis factor blockers and structural remodelling in ankylosing spondylitis: what is reality and what is fiction?
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

  • Published on:
    Comment on “G. Schett et al., Tumour necrosis factor blockers and structural remodelling in ..
    • Frank P Luyten, MD PhD
    • Other Contributors:
      • Rik J. Lories (KU Leuven), Kurt de Vlam (KU Leuven), Dennis McGonagle (Academic Unit of the Musculoskeletal Diseases, University of Leeds, United Kingdom)

    Dear Editor, we read with interest the editorial by Schett et al. on structural remodeling in ankylosing spondylitis. [1] We acknowledge the effort to highlight potential differences between ankylosing spondylitis and rheumatoid arthritis but would like to underline a number of critical issues. Most importantly, the authors did not distinguish the process of new cartilage and bone formation at the enthesis as seen in the di...

    Show More
    Conflict of Interest:
    None declared.